Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Willow Biosciences Inc. (CANSF)

0.0045
+0.0011
+(32.35%)
At close: April 25 at 10:11:05 AM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Chris Savile President, Director & CEO 437.71k -- --
Mr. Travis Doupe Chief Financial Officer 216.54k -- 1972
Dr. Trish Choudhary Senior Vice President of Research & Development 327.11k -- --
Mr. Sanjib Singh Gill L.L.B. Corporate Secretary -- -- 1976

Willow Biosciences Inc.

202, 1201-5th Street SW
Calgary, AB T2R 0Y6
Canada
403-910-5140 https://www.willowbio.com
Sector: 
Healthcare
Full Time Employees: 
19

Description

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

Corporate Governance

Willow Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 12:30 PM UTC - May 16, 2025 at 12:30 PM UTC

Willow Biosciences Inc. Earnings Date

Recent Events

May 21, 2019 at 12:00 AM UTC

Dividend Date

Related Tickers